Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fosamax Fractures-Justice Has Not Been Served.

  • Authors : Curfman G; Executive Editor, JAMA , Chicago, Illinois.

Subjects: Fractures, Bone*/Fractures, Bone*/Fractures, Bone*/chemically induced ; Fractures, Bone*/Fractures, Bone*/Fractures, Bone*/prevention & control ; Alendronate*/Alendronate*/Alendronate*/adverse effects

  • Source: JAMA [JAMA] 2024 Jun 11; Vol. 331 (22), pp. 1887-1888.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Accuracy of Labeling of Galantamine Generic Drugs and Dietary Supplements.

  • Authors : Cohen PA; Department of Medicine, Cambridge Health Alliance, Somerville, Massachusetts.; Jacobs B

Subjects: Dietary Supplements* ; Drugs, Generic* ; Galantamine*

  • Source: JAMA [JAMA] 2024 Mar 19; Vol. 331 (11), pp. 974-976.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers.

Subjects: Drug Labeling* ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/etiology

  • Source: JAMA [JAMA] 2024 Mar 12; Vol. 331 (10), pp. 818-820.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling.

  • Authors : Gyawali B; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Division of Cancer Care and Epidemiology, Department of Oncology, Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

Subjects: Drug Approval* ; Drug Labeling*; Humans

  • Source: JAMA internal medicine [JAMA Intern Med] 2021 Jul 01; Vol. 181 (7), pp. 897-898.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print

Record details

×
Academic Journal

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs.

  • Authors : Naci H; Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.; Guan X

Subjects: Data Display* ; Drug Labeling*/Drug Labeling*/Drug Labeling*/methods ; Drug Labeling*/Drug Labeling*/Drug Labeling*/standards

  • Source: JAMA internal medicine [JAMA Intern Med] 2021 Nov 01; Vol. 181 (11), pp. 1521-1522.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print

Record details

×
Academic Journal

Assessment of the Safety of Common Medications Used During Pregnancy.

  • Authors : Dude C; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia.; Jamieson DJ

Subjects: Drug Labeling* ; Drug-Related Side Effects and Adverse Reactions* ; Pregnancy*

  • Source: JAMA [JAMA] 2021 Dec 21; Vol. 326 (23), pp. 2421-2422.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.

  • Authors : Walsh BS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Sarpatwari A

Subjects: Drug Approval* ; Drug Labeling* ; Drugs, Generic*

  • Source: JAMA internal medicine [JAMA Intern Med] 2021 Jul 01; Vol. 181 (7), pp. 995-997.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print

Record details

×
Academic Journal

Balancing the Risks and Benefits of Benzodiazepines.

  • Authors : Hirschtritt ME; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.; Olfson M

Subjects: Drug Labeling*; Anxiety Disorders/Anxiety Disorders/Anxiety Disorders/*drug therapy ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*therapeutic use

  • Source: JAMA [JAMA] 2021 Jan 26; Vol. 325 (4), pp. 347-348.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia.

Subjects: Drug Labeling*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Dementia/Dementia/Dementia/*drug therapy

  • Source: JAMA network open [JAMA Netw Open] 2020 Apr 01; Vol. 3 (4), pp. e203630. Date of Electronic Publication: 2020 Apr 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic

Record details

×
Academic Journal

Drug labeling and exposure in neonates.

  • Authors : Laughon MM; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill.; Avant D

Subjects: Pediatrics*; Drug Labeling/Drug Labeling/Drug Labeling/*statistics & numerical data ; Infant, Newborn, Diseases/Infant, Newborn, Diseases/Infant, Newborn, Diseases/*drug therapy

  • Source: JAMA pediatrics [JAMA Pediatr] 2014 Feb; Vol. 168 (2), pp. 130-6.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print

Record details

×
  • 1-10 of  825 results for ""DRUG labeling""